Robert Kim

Insider Reports History

Entity
Individual
Location
C/O 4 D Molecular Therapeutics, Inc., 5858 Horton Street #455, Emeryville, CA
Signature
/s/ Scott Bizily, Attorney-in-Fact for Robert Kim
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Robert Kim:

Stock Role Class Num Shares Value Price $ Report Date Ownership
4D Molecular Therapeutics, Inc. Chief Medical Officer Common Stock 1.6K $29.4K $18.41 Feb 7, 2024 Direct
4D Molecular Therapeutics, Inc. Chief Medical Officer Stock Option (Right to Buy) 54K Feb 5, 2024 Direct

Insider Reports Filed by Robert Kim

Symbol Company Period Transactions Value $ Form Type Date Filed Role
FDMT 4D Molecular Therapeutics, Inc. Feb 7, 2024 0 $0 3/A Feb 7, 2024 Chief Medical Officer
FDMT 4D Molecular Therapeutics, Inc. Feb 5, 2024 10 -$371K 4 Feb 7, 2024 Chief Medical Officer
FDMT 4D Molecular Therapeutics, Inc. Dec 11, 2023 1 $0 4 Dec 13, 2023 Chief Medical Officer
FDMT 4D Molecular Therapeutics, Inc. Mar 24, 2023 0 $0 3 Apr 5, 2023 Chief Medical Officer